Form 4: Pediatrix Medical Group Director McEachin Receives Stock Grant

Director Thomas McEachin acquired 11,427 shares of Pediatrix Medical Group stock on May 8, 2025, as part of an annual equity award.

Summary

• Thomas McEachin, a director of Pediatrix Medical Group, Inc. (MD), reported a transaction involving the company's stock.
• On May 8, 2025, McEachin acquired 11,427 shares of common stock at $0 per share.
• These shares were granted as restricted shares under the company's Amended and Restated 2008 Incentive Compensation Plan, in connection with an annual equity award.
• The shares will vest on May 8, 2026.
• Following the transaction, McEachin directly owns 66,073 shares of Pediatrix Medical Group, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock grant is a routine event, but it signals confidence in the company's future.

Positives

• The grant of restricted stock to a director aligns their interests with those of the shareholders.
• The vesting period of one year encourages the director's continued service and focus on long-term value creation.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This type of stock grant is a common practice for compensating and incentivizing directors in publicly traded companies within the healthcare industry.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity, with the equity component designed to align director interests with shareholder value.
• The size of the grant is likely benchmarked against peer companies in the healthcare services sector to ensure competitiveness.
• Vesting schedules are also standard practice, typically ranging from one to three years.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
• The grant has a minimal impact on employees, customers, suppliers, and creditors.

Key Dates

Keywords

Pediatrix Medical Group, Director, Stock Grant, Form 4, Beneficial Ownership, Equity Award, Restricted Shares, McEachin